Placide Mbala-Kingebeni

Biographic Data

ID9063843
NAMEPlacide Mbala-Kingebeni
GIVEN NAMESPlacide
FAMILY NAMEMbala-Kingebeni
SIGNATUREMBALA-KINGEBENI P
AFFILIATIONSUniversity of Kinshasa
VERIFIEDNo
TOTAL WORKS7
TOTAL CITATIONS0
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Implementation of a One Health Surveillance System in the Democratic Republic of the Congo

    Open AccessPaige Rudin Kinzie, Boniface Lombe et al.ARTICLEEcoHealth2026

    Active animal disease surveillance is essential for detecting zoonotic emerging infectious diseases. In the Democratic Republic of the Congo (DRC), limited infrastructure, economic instability, and armed conflict constrain surveillance capability. This ongoing work to characterize the prevalence of zoonoses like Crimean-Congo hemorrhagic fever virus implements an in-country One Health approach to disease surveillance and capacity building in a li…

  • Assessing mpox knowledge and sexual behaviours within high-risk populations in the Democratic Republic of the Congo

    Open AccessCandice Lemaille, Megan Halbrook et al.ARTICLEBMJ Global Health2026

    BACKGROUND: Historically, the Democratic Republic of the Congo (DRC) has faced the greatest public health burden from mpox, including more than 70 000 probable cases from 1 January 2024 to 2 February 2025. However, there has been a relative paucity of investigation focused on mpox community engagement in DRC, including assessments of disease knowledge and risk perception. METHODS: Given the ongoing Clade I mpox public health emergency of internat…

  • Ocular manifestations of Clade Ib mpox in four South-Kivu health zones, Democratic Republic of the Congo

    Open AccessDeogratias Basedeke Ngoma, Irène Nsimire Ntererwa et al.ARTICLEPLOS Global Public Health2026

    With several international outbreaks ongoing, mpox-related eye disease is increasingly detected, yet data on its prevalence remain limited. We conducted a descriptive cross-sectional study in four health zones in South-Kivu Province, Democratic Republic of the Congo, between November 1, 2024 and January 31, 2025, to describe the clinical features of mpox-related ophthalmic disease in hospitalized patients during the ongoing clade Ib outbreak. Rou…

  • A peer-educator driven approach for sampling populations at increased mpox risk in the Democratic Republic of the Congo

    Open AccessSydney Merritt, Megan Halbrook et al.ARTICLEPLOS Global Public Health2025

    The epidemiological risk factors associated with mpox acquisition and severity in the Democratic Republic of the Congo (DRC) are changing. We assessed perceived mpox risk, and behavioral, clinical and sexual histories among key populations at risk of acquisition through sexual contact. Here, we describe a sampling strategy to enroll participants considered to be at increased risk for mpox infection - men who have sex with men (MSM) and sex worker…

  • The time is now (again) for mpox containment and elimination in Democratic Republic of the Congo

    Open AccessPlacide Mbala-Kingebeni, Placide Mbala‐Kingebeni et al.ARTICLEPLOS Global Public Health2024

    sponsorship: This work was supported by the International Mpox Research Consortium (IMReC) through funding from the Canadian Institutes of Health Research and International Development Research Centre (grant no. MRR-184813 to JK, PMK); Department of Defense, Defense Threat Reduction Agency (Monkeypox Threat Reduction Network grant #HDTRA1-21-1-0040 to AWR). The funders had no role in study design, data collection and analysis, decision to publish…

  • Development of a clinical prediction score for Ebola virus disease screening at triage centers in the Democratic Republic of the Congo

    Open AccessJepsy Yango, Antoine Oloma Tshomba et al.ARTICLEPLOS Global Public Health2024

    The 2018–2020 Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo (DRC) was the largest since the disease‘s discovery in 1976. Rapid identification and isolation of EVD patients are crucial during triage. This study aimed to develop a clinical prediction score for EVD using clinical and epidemiological predictors. We conducted a retrospective cross-sectional study using surveillance data from EVD outbreak, collected during …

  • Seroprevalence of Sars-CoV-2 antibodies and retrospective mortality in two African settings

    Open AccessErica Simons, Birgit Nikolay et al.ARTICLEPLOS Global Public Health2023

    Although seroprevalence studies have demonstrated the wide circulation of SARS-COV-2 in African countries, the impact on population health in these settings is still poorly understood. Using representative samples of the general population, we evaluated retrospective mortality and seroprevalence of anti-SARS-CoV-2 antibodies in Lubumbashi and Abidjan. The studies included retrospective mortality surveys and nested anti-SARS-CoV-2 antibody prevale…